medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2019, Number 1

<< Back Next >>

Ann Hepatol 2019; 18 (1)

Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center

Kuftinec GN, Levy R, Kieffer DA, Medici V

Language: English
References: 31
Page: 177-186
PDF size: 195.00 Kb.


ABSTRACT

Introduction and aim. Hepatocellular carcinoma (HCC) is the most common type of liver cancer in adults and has seen a rapid increase in incidence in the United States. Racial and ethnic differences in HCC incidence have been observed, with Latinos showing the greatest increase over the past four decades, highlighting a concerning health disparity. The goal of the present study was to compare the clinical features at the time of diagnosis of HCC in Latino and Caucasian patients. Material and methods. We retrospectively screened a total of 556 charts of Latino and Caucasian patients with HCC. Results. The mean age of HCC diagnosis was not significantly different between Latinos and Caucasians, but Latinos presented with higher body mass index (BMI). Rates of hypertension, diabetes, and hyperlipidemia were similar in the two groups. The most common etiology of liver disease was alcohol drinking in Latinos, and chronic hepatitis C in Caucasian patients. Non-Alcoholic Steatohepatitis (NASH) was the associated diagnosis in 8.6% of Latinos and 4.7% of Caucasians. Interestingly, alpha-fetoprotein (AFP) levels at time of diagnosis were higher in Latino patients compared to Caucasians, but this difference was evident only in male patients. Multifocal HCC was slightly more frequent in Latinos, but the two groups had similar cancerous vascular invasion. Latino patients also presented with higher rates of both ascites and hepatic encephalopathy. Conclusion. Latino and Caucasian patients with HCC present with a different profile of etiologies, but cancer features appear to be more severe in Latinos.


REFERENCES

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386.

  2. Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 2013; 47(Suppl.): S2-S6.

  3. Singal AG, El-Serag HB. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clin Gastroenterol Hepatol 2015; 13: 2140-51.

  4. El-Serag HB. Hepatocellular carcinoma. New Engl J Med 2011; 365: 1118-27.

  5. Altekruse SF, Mcglynn KA, Dickie LA, Kleiner DE. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology 2012; 55: 476-82.

  6. Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis 2008; 5: A74.

  7. El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med 2007; 167: 1983-9.

  8. Wong R, Corley DA. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med 2008; 121: 525-31.

  9. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007; 37(Suppl. 2): S88-S94.

  10. Census Brief 2010: The Hispanic Population. 2010.

  11. Venepalli NK, Modayil MV, Berg SA, Nair TD, Parepally M, Rajaraman P, Gaba RC, et al. Features of hepatocellular carcinoma in Hispanics differ from African Americans and non- Hispanic Whites. World J Hepatol 2017; 9: 391-400.

  12. Ramirez AG, Weiss NS, Holden AE, Suarez L, Cooper SP, Munoz E, Naylor SL. Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research. PloS One 2012; 7: e35573.

  13. Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, Jemal A. Cancer statistics for Hispanics/ Latinos, 2015. CA Cancer J Clin 2015; 65: 457-80.

  14. Younossi ZM, Stepanova M. Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States. Clin Gastroenterol Hepatol 2010; 8: 718- 23.

  15. Diabetes Report Card 2012: National and State Profile of Diabetes and Its Complications. 2012.

  16. Setiawan VW, Hernandez BY, Lu SC, Stram DO, Wilkens LR, Le marchand L, Henderson BE. Diabetes and racial/ethnic differences in hepatocellular carcinoma risk: the multiethnic cohort. J Natl Cancer Inst 2014; 106.

  17. Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015; 148; 547-55.

  18. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003; 124: 71-9.

  19. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311: 806-14.

  20. Hispanic Population and Origin in Select U.S. Metropolitan Areas, 2014. Accessed on 05/22/2018, (2016). URL: http:// www.pewhispanic.org/interactives/hispanic-population-inselect- u-s-metropolitan-areas/.

  21. Altekruse SF, Henley SJ, Cucinelli JE, Mcglynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 2014; 109; 542-53.

  22. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of liver-related mortality in the United States. Gastroenterology 2013; 145: 375-82.

  23. Flores YN, Yee HF, Jr., Leng M, Escarce JJ, Bastani R, Salmeron J, Morales LS. Risk factors for chronic iver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol 2008; 103: 2231-8.

  24. Ha J, Yan M, Aguilar M, Bhuket T, Tana MM, Liu B, Gish RG, et al. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Cancer 2016; 122: 2512-23.

  25. Bambha K, Belt P, Abraham M, Wilson LA, Pabst M, Ferrell L, Unalp-Arida A, et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012; 55: 769-80.

  26. Setiawan VW, Wei PC, Hernandez BY, Lu SC, Monroe KR, Le Marchand L, Yuan JM. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort. Cancer 2016; 122: 1444-52.

  27. Babalola A, Miksad RA, Oladunjoye O, Nwosu U, Castro- Webb N, Srivastava N, Burns B, et al. Comparison of Hispanic and non-Hispanic patients with HCC. J Clin Oncol 2014; 32(30_Suppl.): 294.

  28. Aparo S, Goel S, Lin D, Ohri N, Schwartz JM, Lo Y, Kaubisch A. Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma. Cancer 2014; 120: 3683-90.

  29. Li J, Hansen BE, Peppelenbosch MP, De Man RA, Pan Q, Sprengers D. Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma. Oncotarget 2017; 8: 15193-204.

  30. Ha J, Chaudhri A, Avirineni A, Pan JJ. Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review. Biomark Res 2017; 5: 15.

  31. Nguyen P, Le AK, Hoang J, Yasukawa LA, Weber SC, Stefanick ML, Garcia G, Nguyen MH. Higher Rates of Cirrhosis, Hepatic Decompensation, and Hepatocellular Carcinoma (HCC) in Asian and Hispanic Patients with Hepatitis C (HCV) Infection Compared to White and Black Ethnicity Regardless of Gender Differences: A Single Center Retrospective Cohort Study. Gastroenterology 2017; 152: S1166.




2020     |     www.medigraphic.com